Medtronic plc, Fresenius SE & Co. KGaA, and Haemonetics Corporation – are Notable Market Players in the Autotransfusion Devices Market
The autotransfusion devices market is highly competitive, with a considerable number of players operating in the market. Most of the companies operating in the autotransfusion devices market are present across the globe and have wide distribution and sales networks through partnerships or authorized dealers.
The most notable market players are BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet among others occupying a considerable share of the market owing to their offerings to the market.
The major market players within recent years have been observed to invest a substantial amount towards the development of products. This implies a vivid picture of the type of strategies majorly incorporated by the market players to sustain their positions as well as to generate increased growth revenue in the autotransfusion devices market. The global leaders in the market have been majorly adopting product launches, acquisition, agreements, and a key strategy to improve its product lines to build up customer-centric benefits to its end-users and enhance its geographic diversification.
For instance, in December 2017, BD has acquired C. R. Bard, Inc. It has created a new health care industry leader with approximately US$ 16 billion in annualized revenue. The company under the subsidiary Bard offers autotransfusion related products and services. Thus, the acquisition of C.R Bard, BD is enabled to offers products and services to its customers. The strategic moves has also enabled the growth of company along with the market growth.
